Spark prices the first US gene therapy drug at $850,000 — which is actually less than expected
January 03, 2018 at 08:30 AM EST
The price is for Spark Therapeutics' Luxturna, approved by the FDA in December to treat a rare, inherited retinal disease that can lead to blindness.
